Health Promotion Board

Aoxin Q & M acquires 49% stake in Acumen Diagnostics for S$29.4m

Retrieved on: 
Monday, October 4, 2021
Acumen, People, PCR, Singapore Exchange, ASEAN, Population, Bloodstream infections, Sepsis, Growth, City, Health Promotion Board, Industry, Vaccine, Exercise, Health, Learning, HPB, COVID-19 testing, Technology, SGX, Dentist, Fever Dream, The Group, Vaccination, Infection, Ministry, Solution, Sale, List of health departments and ministries, Cancer, Hospital, Acquisition, Catalist, Republic, Percussion section, Patent, Diagnosis, Mission statement, Motherboard, Ownership, Board, Private sector, Family, Q. M. Pyne Store, COVID-19, Pneumonia, Research, Board of directors, Real estate, Animal, Security (finance), Medical device, Pharmaceutical industry, Dentistry, Health insurance

- Aoxin Q & M acquires a stake in Acumen Diagnostics, one of the leading homegrown medical diagnostics and technology companies in Singapore

Key Points: 
  • - Aoxin Q & M acquires a stake in Acumen Diagnostics, one of the leading homegrown medical diagnostics and technology companies in Singapore
    - With Q & M holding a majority 51% stake in Acumen Diagnostics, the acquisition, upon completion, raises Q & M's total effective ownership in Acumen Diagnostics to 67.15%, based on Q & M's 32.95% equity stake in Aoxin Q & M
    - Acquisition will be immediately profit accretive; presents opportunity to assist in providing an essential capability to Singapore in this next phase of tackling the COVID-19 pandemic, as the availability of good quality test kits and testing services will be an important cog in the national response to treating and living with COVID-19
    SINGAPORE, Oct 4, 2021 - (ACN Newswire) - Aoxin Q & M Dental Group Ltd (SGX: 1D4.SI) ("Aoxin Q & M") and Q & M Dental Group (Singapore) Limited (SGX: QC7.SI) ("Q & M"), announced today that Aoxin Q & M will acquire 49% of Acumen Diagnostics Pte.
  • Q & M's total effective ownership of Acumen Diagnostics will thus amount to 67.15%, based on its 32.95% equity stake in Aoxin Q & M. See diagram 1 below.
  • The Board of Directors of Aoxin Q & M believes that the proposed acquisition will enhance the long-term interests of Aoxin Q & M and its shareholders.
  • Q & M supports this transaction, and this transaction is likely to be beneficial to Q & M and its shareholders and financially strengthen Q & M and Aoxin Q & M in the mid and long term."

Fitbit Collaborates with Singapore’s Health Promotion Board on Population-Based Public Health Initiative in Singapore

Retrieved on: 
Wednesday, August 21, 2019
Software, General Health, Mobile, Wireless, Hardware, Data management, Consumer electronics, Technology, Fitness & Nutrition, Health, Articles, Health, Fashion accessories, Wearable devices, Ambient intelligence, Internet of things, Ubiquitous computing, Fitbit, Health Promotion Board, Health promotion, Wearable computer, HPB

Fitbit (NYSE: FIT), today announced that it will be collaborating with Singapores Health Promotion Board (HPB) on a healthy population project in support of Singapores Smart Nation initiative.

Key Points: 
  • Fitbit (NYSE: FIT), today announced that it will be collaborating with Singapores Health Promotion Board (HPB) on a healthy population project in support of Singapores Smart Nation initiative.
  • This is Fitbits first major integration of a digital health platform and wearables into a national public health program globally.
  • The insights gathered can also help to enrich HPBs health promotion programs, said Zee Yoong Kang, CEO, Health Promotion Board.
  • Fitbit Health Solutions develops health and wellness solutions designed to help increase engagement, improve health outcomes, and drive a positive return for employers, health plans and health systems.